Document is current
Any future updates will be listed below
-
Authors
Gao, Yibo
Hu, Ping
Wu, Ning
Tan, Fengwei
Cao, Wei
Tang, Wei
Wang, Fei
Li, Jiang
Li, Xin
Wen, Yan
Xu, Yongjie
Yu, Yiwen
Qin, Chao
Dong, Xuesi
Ren, Jiansong
Yang, Zhuoyu
Zheng, Yadi
Wu, Zheng
Pinsky, Paul
Prorok, Philip
Taylor, Martina
Li, Ni
Kramer, Barnett
He, Jie
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China Stem Cell and Translational Research (2017YFC1308700/2017YFC1308703)
National Key Research and Development Program of China (2021YFC2500900/2021YFC2500904, 2018YFC1315000/2018YFC1315001, 2021YFC2500900/2021YFC2500904, 2018YFC1315000/2018YFC1315001)
National Natural Science Foundation of China (82273722, 81871885, 82204143, 82273722, 81871885, 82204143, 82273722, 81871885, 82204143)
the Special Research Fund for Central Universities, Peking Union Medical College (3332022031)
the Chinese Academy of Medical Sciences Innovation Fund for Medical Science (2021-I2M-1-011, 2021-I2M-1-067, 2021-I2M-1-011, 2021-I2M-1-067)
non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences (2019PT320027)
- License Information
-
More Information
Article History
Received: 17 April 2024
Accepted: 14 April 2025
First Online: 17 April 2025
Declarations
:
: The study has been approved by the independent ethics committee of the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (19/167–1951), and the approval will be renewed annually. This study is performed in accordance with the Declaration of Helsinki. Participants will only be included when oral and written consent have been provided by the participant, or their legal guardians by proxy where appropriate.
: Not applicable.
: The authors declare no competing interests.
